secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001193125-23-027742
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight prices public offering of 4M shares at $12.50 each for ~$50M gross proceeds
--------------------------------------------------------------------------------

- Offering of 4,000,000 shares of common stock at $12.50 per share; gross proceeds ~$50.0M, net ~$46.7M.
- Underwriters granted 30-day option to purchase up to 600,000 additional shares at same price.
- Offering expected to close February 10, 2023; BofA Securities sole bookrunning manager.
- Net proceeds to fund commercial expansion, product development, R&D, and working capital.
- Officers and directors subject to 90-day lock-up restrictions on share sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312523027742/0001193125-23-027742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312523027742/d426433d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-027742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer